Compare Injective (INJ) vs NEAR Protocol (NEAR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs NEAR Protocol — how do they compare? Injective trades at Rp76,143 (market cap Rp7,62T, Rp1,22T 24h volume), while NEAR Protocol trades at Rp28,641 (market cap Rp37T, Rp1,95T 24h volume). The key difference: NEAR Protocol is far larger — about 4.9× Injective's market cap, and Injective's circulating supply is 100M INJ versus 1,3B NEAR for NEAR Protocol. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 37 Days and NEAR Protocol for 51 Days on average.
| INJ | NEAR | |
|---|---|---|
Market Cap | Rp7,62T | Rp37T |
Volume (24h) | Rp1,22T | Rp1,95T |
Circulating Supply | 100M INJ | 1,3B NEAR |
Typical Hold Time | 37 Days | 51 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is currently trading at Rp75,554 with a market cap of Rp7.49T, exhibiting a bearish technical signal as indicated by moving averages. The asset trades below its pivot point of Rp82,186, with key support at Rp81,456 and resistance at Rp82,576. Recent on-chain data shows an average hold time of 37 days, suggesting moderate holding behavior.
The overall outlook is cautious due to bearish technical indicators and neutral oscillators. Key opportunities lie in potential rebounds from support levels, while major risks include high volatility and the absence of recent significant protocol updates. Investors should monitor trading volume and broader crypto market trends closely.
NEAR Protocol is currently trading at Rp28,499 with a market cap of Rp37T, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token faces immediate resistance at Rp29,779 and support at Rp28,880, with RSI levels suggesting neither overbought nor oversold conditions. Recent news highlights NEAR's positioning as a potential beneficiary in a lower interest rate environment.
Overall outlook remains cautious with technical indicators favoring sellers, though neutral oscillators suggest potential stabilization. Key opportunities include protocol utility in decentralized applications, while risks involve crypto market volatility and regulatory uncertainty. Investors should monitor support levels and broader market sentiment.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About NEAR Protocol
NEAR is a sharded, developer-friendly, proof-of-stake public blockchain, built by a world-class team that has built some of the world's only sharded databases at scale. The network runs on a Proof-of-Stake (PoS) convention mechanism called Nightshade, which aims to offer scalability and stable costs. nn
Read more on NEAR →
